|
RALA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.64750000000358E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.538650E-03 |
| Normal-vs-Stage2 |
4.921500E-02 |
| Normal-vs-Stage3 |
1.310410E-01 |
| Normal-vs-Stage4 |
1.048230E-01 |
| Stage1-vs-Stage2 |
7.719400E-01 |
| Stage1-vs-Stage3 |
9.047200E-01 |
| Stage1-vs-Stage4 |
8.299600E-01 |
| Stage2-vs-Stage3 |
7.651800E-01 |
| Stage2-vs-Stage4 |
9.981400E-01 |
| Stage3-vs-Stage4 |
8.125400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.029050E-04 |
| Normal-vs-AfricanAmerican |
3.801100E-03 |
| Normal-vs-Asian |
4.702200E-01 |
| Caucasian-vs-AfricanAmerican |
9.142400E-01 |
| Caucasian-vs-Asian |
7.929000E-01 |
| AfricanAmerican-vs-Asian |
8.063200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.23980000000946E-05 |
| Normal-vs-Female |
1.199550E-03 |
| Male-vs-Female |
9.194600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.874230E-01 |
| Normal-vs-Extreme_Weight |
2.878100E-03 |
| Normal-vs-Obese |
4.611900E-04 |
| Normal-vs-Extreme_Obese |
6.449400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.415400E-01 |
| Normal_Weight-vs-Obese |
1.422220E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.958600E-01 |
| Extreme_Weight-vs-Obese |
5.220000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.051200E-01 |
| Obese-vs-Extreme_Obese |
2.318200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.182500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.0408999999928E-05 |
| Normal-vs-Age(61-80Yrs) |
2.497900E-03 |
| Normal-vs-Age(81-100Yrs) |
5.436200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.087200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.815000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.357990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.627200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.453800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.066400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.83500000539416E-08 |
| Normal-VS-Type2 PRCC |
8.548600E-01 |
| Normal-VS-KIRP CIMP |
2.479500E-03 |
| Normal-VS-Unclassified PRCC |
5.884500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.99419999975015E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.640400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.853800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.993000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.255700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.970100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.577200E-01 |
| Normal-vs-N1 |
8.261900E-03 |
| Normal-vs-N2 |
3.514600E-01 |
| N0-vs-N1 |
8.915000E-03 |
| N0-vs-N2 |
6.010000E-01 |
| N1-vs-N2 |
4.844200E-01 |
|
|
